Wan Ling Tan
- Co-authors
- Brian K. P. GohAndrew X. ZhuWai Meng David TaiSu Pin ChooAmit JainWan‐Teck LimQuan Sing NgBalram Chowbay
- Topics
- Lung Cancer Treatments and Mutations (12 papers)Cancer Immunotherapy and Biomarkers (6 papers)Gastric Cancer Management and Outcomes (6 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- SingaporeUnited StatesTaiwan
In The Last Decade
Wan Ling Tan
20 papers receiving 405 citations
Peers
Comparison fields: 5 of 59
- Pulmonary and Respiratory Medicine 152
- Oncology 149
- Hepatology 144
- Cancer Research 92
- Epidemiology 85
Countries citing papers authored by Wan Ling Tan
This map shows the geographic impact of Wan Ling Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Ling Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Ling Tan more than expected).
Fields of papers citing papers by Wan Ling Tan
This network shows the impact of papers produced by Wan Ling Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Ling Tan. The network helps show where Wan Ling Tan may publish in the future.
Co-authorship network of co-authors of Wan Ling Tan
This figure shows the co-authorship network connecting the top 25 collaborators of Wan Ling Tan. A scholar is included among the top collaborators of Wan Ling Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan Ling Tan. Wan Ling Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 14 | |
| 5 | 1 | |
| 6 | 7 | |
| 7 | 2 | |
| 8 | 40 | |
| 9 | 5 | |
| 10 | 2 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | 12 | |
| 14 | 3 | |
| 15 | 61 | |
| 16 | 5 | |
| 17 | 210 | |
| 18 | 7 | |
| 19 | 8 | |
| 20 | 20 |
About Wan Ling Tan
Wan Ling Tan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology, having authored 22 papers that have together received 407 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Hepatology (144 citations), Cancer Research (92 citations) and Oncology (149 citations). Wan Ling Tan has collaborated with scholars based in Singapore, United States and Taiwan. Frequent co-authors include Brian K. P. Goh, Andrew X. Zhu, Wai Meng David Tai, Su Pin Choo, Amit Jain, Wan‐Teck Lim, Quan Sing Ng, Balram Chowbay, Ravindran Kanesvaran and Chee‐Keong Toh. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.